iSolve Leveraging the Blockchain to Bring Lifesaving Drugs to Market
iSolve has recently launched a new platform which brings Biotech Entrepreneurs, Tech Transfer Offices, Investors, and Service providers together to post, track, bid and partner on business opportunities.
The goal is to have a Visible, Traceable, and Transparent process to help new companies get the funding and services they need to bring new medications to the global marketplace. It is the first organization to use the Blockchain to create an Entrepreneurial Marketplace and Global IP Exchange.
iSolve is dedicated to helping the community grow through collaboration, partnerships and technology. By utilizing the Blockchain, iSolve seeks to create a virtual marketplace for the expansion and growth of Biotech Companies, Investors and Service Providers. All Biotech assets and initiatives will be recorded on the Blockchain distributed ledger.
The new global business environment, facilitated by tools like the internet, has improved connectivity and ease of information, yet there is still no secure and centralized means for collaboration. With no centralized platform, Biotechs, Investors, Service Providers, and Tech Transfer Offices will have to rely upon more traditional channels for funding and services. iSolve will eliminate this issue and provide greater functionality for managing the process, communication and collaboration between all parties for New Drug Development and Global IP Exchange. The key metric that will change is the speed, visibility and security our members will obtain by leveraging iSolve and the Blockchain to reach the global market.
About iSolve
The core team for iSolve are highly skilled professionals with over 20 years of experience in Finance, Technology, Healthcare, and Government. iSolve, LLC. was founded in East Norriton, PA in 2014 and is focused on the use of the Blockchain and the implications of the Blockchain as an immutable digital ledger of transactions for the Life Sciences Industry. The team is already looking at a wide range of uses for other IP assets and Social Enterprises that face similar challenges to new Biotech/Pharma Companies. Moving forward, iSolve will expand this platform beyond Biotech to every industry founded on technological innovation or to help Social Enterprises.
For more information, please visit: http://www.iSolve.io/
Related News